Generis Capital Partners, alongside Montpensier Arbevel, has acquired a majority stake in Luquet & Duranton to support its growth strategy focused on expanding digital capabilities in healthcare solutions.
Target Information
The Luquet & Duranton Group is a leading player in printed products and traceability solutions specifically designed for healthcare institutions. Established in 1898 in Annonay, the company has undergone several generations of family ownership and was acquired in 2008 by Florent Emy and Max Braha-Lonchant. Under their leadership, the company has successfully evolved and repositioned itself to meet the unique needs of the healthcare sector.
Originally an expert in technical printing, Luquet & Duranton has diversified its offerings over the years, now providing an extensive range of products and solutions aimed at hospitals and other healthcare facilities. Their product lineup includes printed materials (such as secure order forms and patient admission pockets) and both physical and digital traceability solutions. Through its software subsidiary, Ad'Valorem, which is wholly owned, the company offers innovative digital solutions alongside traditional printed products.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
In recent years, the healthcare industry in France has been experiencing significant transformations, largely driven by technological advancements and the increasing demand for efficient healthcare s
Similar Deals
SK Capital Partners → LISI Group's Medical division
2025
Asker Healthcare Group → Finmed SAS
2025
Generis Capital Partners
invested in
LUQUET & DURANTON
in 2025
in a Buyout deal